These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 10502725
1. Alteration of pRb/p16/cdk4 regulation in human osteosarcoma. Benassi MS, Molendini L, Gamberi G, Ragazzini P, Sollazzo MR, Merli M, Asp J, Magagnoli G, Balladelli A, Bertoni F, Picci P. Int J Cancer; 1999 Oct 22; 84(5):489-93. PubMed ID: 10502725 [Abstract] [Full Text] [Related]
2. Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma. Asp J, Inerot S, Block JA, Lindahl A. J Orthop Res; 2001 Jan 22; 19(1):149-54. PubMed ID: 11332612 [Abstract] [Full Text] [Related]
3. [The expression of p16, CDK4 and pRb in hepatocellular carcinomas]. Luo D, Liu Q, Su J. Zhonghua Gan Zang Bing Za Zhi; 1999 Jun 22; 7(2):94-5. PubMed ID: 10488417 [Abstract] [Full Text] [Related]
4. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations. Nielsen GP, Burns KL, Rosenberg AE, Louis DN. Am J Pathol; 1998 Jul 22; 153(1):159-63. PubMed ID: 9665476 [Abstract] [Full Text] [Related]
5. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas. Burns KL, Ueki K, Jhung SL, Koh J, Louis DN. J Neuropathol Exp Neurol; 1998 Feb 22; 57(2):122-30. PubMed ID: 9600204 [Abstract] [Full Text] [Related]
6. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J. Cancer Res; 1996 Dec 01; 56(23):5475-83. PubMed ID: 8968104 [Abstract] [Full Text] [Related]
7. Altered G1 phase regulation in osteosarcoma. Benassi MS, Molendini L, Gamberi G, Sollazzo MR, Ragazzini P, Merli M, Magagnoli G, Sangiorgi L, Bacchini P, Bertoni F, Picci P. Int J Cancer; 1997 Oct 21; 74(5):518-22. PubMed ID: 9355974 [Abstract] [Full Text] [Related]
8. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features. Semczuk A, Miturski R, Skomra D, Jakowicki JA. Arch Gynecol Obstet; 2004 Jan 21; 269(2):104-10. PubMed ID: 14648178 [Abstract] [Full Text] [Related]
9. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O. Br J Cancer; 1996 Apr 21; 73(8):909-16. PubMed ID: 8611425 [Abstract] [Full Text] [Related]
10. Alteration of the CDKN2/p16 gene is not required for HPV-positive uterine cervical cancer cell lines. Yoshinouchi M, Hongo A, Takamoto N, Ono Y, Nagao S, Miyagi Y, Kudo T, Kodama J. Int J Oncol; 2000 Mar 21; 16(3):537-41. PubMed ID: 10675486 [Abstract] [Full Text] [Related]
11. Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon. Bartkova J, Thullberg M, Slezak P, Jaramillo E, Rubio C, Thomassen LH, Bartek J. Gastroenterology; 2001 Jun 21; 120(7):1680-8. PubMed ID: 11375949 [Abstract] [Full Text] [Related]
12. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK, Medina D. Mol Carcinog; 1998 Jun 21; 22(2):128-43. PubMed ID: 9655257 [Abstract] [Full Text] [Related]
13. [The effects of exogenous p16 expression on CDK4, Cyclin D1 and pRb in nasopharyngeal carcinoma cell lines]. Zhao XR, Deng L, Weng XX. Hunan Yi Ke Da Xue Xue Bao; 2000 Oct 28; 25(5):428-30. PubMed ID: 12212108 [Abstract] [Full Text] [Related]
14. Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells. Craig C, Kim M, Ohri E, Wersto R, Katayose D, Li Z, Choi YH, Mudahar B, Srivastava S, Seth P, Cowan K. Oncogene; 1998 Jan 15; 16(2):265-72. PubMed ID: 9464545 [Abstract] [Full Text] [Related]
15. Expression of p16 and cyclin-dependent kinase 4 proteins in primary breast carcinomas. Ito Y, Kobayashi T, Takeda T, Nakano Y, Tamaki Y, Komoike Y, Wakasugi E, Shin E, Takatsuka Y, Kikkawa N, Matsuura N, Monden M. Oncology; 1997 Jan 15; 54(6):508-15. PubMed ID: 9394849 [Abstract] [Full Text] [Related]
16. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. He J, Olson JJ, James CD. Cancer Res; 1995 Nov 01; 55(21):4833-6. PubMed ID: 7585516 [Abstract] [Full Text] [Related]
17. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B, Windhager R, Gadner H. Oncogene; 1997 Oct 01; 15(18):2225-32. PubMed ID: 9393981 [Abstract] [Full Text] [Related]
18. The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer. Kusume T, Tsuda H, Kawabata M, Inoue T, Umesaki N, Suzuki T, Yamamoto K. Clin Cancer Res; 1999 Dec 01; 5(12):4152-7. PubMed ID: 10632354 [Abstract] [Full Text] [Related]
19. [Expression and regulation of p16 in osteosarcoma]. Shi X, Ma Z, Wang D, Liang Y, Li H, Wang J. Zhonghua Wai Ke Za Zhi; 1999 Dec 01; 37(12):733-6. PubMed ID: 11829939 [Abstract] [Full Text] [Related]
20. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas. Kishimoto I, Mitomi H, Ohkura Y, Kanazawa H, Fukui N, Watanabe M. J Surg Oncol; 2008 Jul 01; 98(1):60-6. PubMed ID: 18484097 [Abstract] [Full Text] [Related] Page: [Next] [New Search]